Save your place

Sign in to WhoBought

Please try again later.

Tarsus Pharmaceuticals, Inc. (TARS) institutional ownership

Latest close $57.26 Jul 21, 2026
Market cap$1.7B 52-week range SectorHealthcare
Funds holding · Q1 2026
244
reported TARS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
129 buyers · 115 sellers

Tarsus Pharmaceuticals, Inc. (TARS) price and institutional activity

Dates

Q1 2026

$0 bought by 129 investors
Deep Track Capital, LPMillennium Management LLC +127 more
$0 sold by 115 investors
Jennison Associates LLCInvesco Ltd. +113 more
Bought Sold Totals per quarter; hover a bar for the names.

Tarsus Pharmaceuticals, Inc. (TARS) institutional activity · 244

Investor Type Est. change Change Δ Own Date
Deep Track Capital, LP · Added
Change +596K Date Q1 2026
Deep Track Capital, LP Added· Q1 2026 +596K Q1 2026
Jennison Associates LLC · Reduced
Change −518K Date Q1 2026
Jennison Associates LLC Reduced· Q1 2026 −518K Q1 2026
Millennium Management LLC · Added
Change +448K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +448K Q1 2026
Bank of America Corp · Added
Change +436K Date Q1 2026
Bank of America Corp Added· Q1 2026 +436K Q1 2026
Janus Henderson Group PLC · Added
Change +311K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +311K Q1 2026
Invesco Ltd. · Reduced
Change −270K Δ Own −26.7% Date Q1 2026
Invesco Ltd. Reduced· Q1 2026 −270K −26.7% Q1 2026
Braidwell LP · New
Change +266K Date Q1 2026
Braidwell LP New· Q1 2026 +266K Q1 2026
Tri Locum Partners LP · New
Change +253K Date Q1 2026
Tri Locum Partners LP New· Q1 2026 +253K Q1 2026
Driehaus Capital Management LLC · Reduced
Change −246K Date Q1 2026
Driehaus Capital Management LLC Reduced· Q1 2026 −246K Q1 2026
T. Rowe Price Associates · Reduced
Change −244K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −244K Q1 2026
BlackRock · Reduced
Change −238K Date Q1 2026
BlackRock Reduced· Q1 2026 −238K Q1 2026
Squarepoint Ops LLC · Added
Change +219K Date Q1 2026
Squarepoint Ops LLC Added· Q1 2026 +219K Q1 2026
Vestal Point Capital, LP · New
Change +200K Date Q1 2026
Vestal Point Capital, LP New· Q1 2026 +200K Q1 2026
Point72 Asset Management, L.P. · Added
Change +189K Δ Own +501.3% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +189K +501.3% Q1 2026
D. E. Shaw & Co., Inc. · Added
Change +176K Δ Own +28.6% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +176K +28.6% Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 244

Famous investor activity in Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals, Inc. (TARS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Goodrich Katherine · Director 2 operations 6K
Owned 2K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Goodrich Katherine Director 2 operations 6K 2K Jun 25, 2026 Jun 29, 2026
Goldberg Andrew D. · Director 2 operations 6K
Owned 2K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Goldberg Andrew D. Director 2 operations 6K 2K Jun 25, 2026 Jun 29, 2026
Morrison Scott W. · Director 2 operations 6K
Owned 2K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Morrison Scott W. Director 2 operations 6K 2K Jun 25, 2026 Jun 29, 2026
Chaudhuri Bhaskar · Director 2 operations 6K
Owned 2K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Chaudhuri Bhaskar Director 2 operations 6K 2K Jun 25, 2026 Jun 29, 2026
Yarno Wendy L. · Director 3 operations 7K
Owned 1K Trade date Jun 25, 2026 Filed date Jun 29, 2026
Yarno Wendy L. Director 3 operations 7K 1K Jun 25, 2026 Jun 29, 2026
Pyott David E. I. · Director 3 operations 7K
Owned 806 Trade date Jun 25, 2026 Filed date Jun 29, 2026
Pyott David E. I. Director 3 operations 7K 806 Jun 25, 2026 Jun 29, 2026
Link William J. Phd · Director 3 operations 7K
Owned 806 Trade date Jun 25, 2026 Filed date Jun 29, 2026
Link William J. Phd Director 3 operations 7K 806 Jun 25, 2026 Jun 29, 2026
Azamian Bobak R. · Director 2 operations −$615K
Price $61.24–$61.81 Qty −10K Owned 848K ΔOwn −1.2% Trade date Jun 17, 2026 Filed date Jun 22, 2026
Azamian Bobak R. Director 2 operations $61.24–$61.81 −10K −$615K 848K −1.2% Jun 17, 2026 Jun 22, 2026
Farrow Jeffrey S. · Officer Sell −$877K
Price $60.95 Qty −14K Owned 57K Trade date Jun 16, 2026 Filed date Jun 17, 2026
Farrow Jeffrey S. Officer Sell $60.95 −14K −$877K 57K Jun 16, 2026 Jun 17, 2026
Farrow Jeffrey S. · Officer 2 operations 0
Owned 28K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Farrow Jeffrey S. Officer 2 operations 0 28K Jun 15, 2026 Jun 17, 2026
Goodrich Katherine · Director Sell −$183K
Price $62.08 Qty −3K Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Goodrich Katherine Director Sell $62.08 −3K −$183K 2K Jun 15, 2026 Jun 17, 2026
Link William J. Phd · Director 2 operations −$776K
Price $61.97–$62.94 Qty −12K Owned 107K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Link William J. Phd Director 2 operations $61.97–$62.94 −12K −$776K 107K Jun 15, 2026 Jun 17, 2026
Morrison Scott W. · Director 2 operations 0
Owned 0 Trade date Jun 12, 2026 Filed date Jun 16, 2026
Morrison Scott W. Director 2 operations 0 0 Jun 12, 2026 Jun 16, 2026
Link William J. Phd · Director 2 operations 0
Owned 0 Trade date Jun 12, 2026 Filed date Jun 16, 2026
Link William J. Phd Director 2 operations 0 0 Jun 12, 2026 Jun 16, 2026
Chaudhuri Bhaskar · Director 2 operations 0
Owned 0 Trade date Jun 12, 2026 Filed date Jun 16, 2026
Chaudhuri Bhaskar Director 2 operations 0 0 Jun 12, 2026 Jun 16, 2026
15 of 72
15 of 72 Sign in to continue to older insider transactions.

Tarsus Pharmaceuticals, Inc. (TARS) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Blackrock, Inc. 3.8M
% of shares outstanding 9.9% Filing date Nov 8, 2024
Blackrock, Inc. 3.8M 9.9% Nov 8, 2024
Rtw Investments, LP 3.2M
% of shares outstanding 9.5% Filing date Feb 14, 2024
Rtw Investments, LP 3.2M 9.5% Feb 14, 2024
Deep Track Capital, LP 3.6M
% of shares outstanding 8.5% Filing date May 15, 2026
Deep Track Capital, LP 3.6M 8.5% May 15, 2026
BlackRock Inc. 2.5M
% of shares outstanding 7.6% Filing date Jan 26, 2024
BlackRock Inc. 2.5M 7.6% Jan 26, 2024
Tang Capital Partners LP 2.2M
% of shares outstanding 6.7% Filing date Feb 14, 2024
Tang Capital Partners LP 2.2M 6.7% Feb 14, 2024
Paradigm Biocapital Advisors LP 2.4M
% of shares outstanding 6.4% Filing date Nov 14, 2024
Paradigm Biocapital Advisors LP 2.4M 6.4% Nov 14, 2024
Morgan Stanley 1.9M
% of shares outstanding 5.9% Filing date Feb 9, 2024
Morgan Stanley 1.9M 5.9% Feb 9, 2024
Cowen Financial Products LLC 1.9M
% of shares outstanding 5.8% Filing date Feb 2, 2024
Cowen Financial Products LLC 1.9M 5.8% Feb 2, 2024
8 of 18

Tarsus Pharmaceuticals, Inc. (TARS) ownership FAQ

Who owns TARS?

244 reporting institutions disclosed TARS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.